IVF Hartmann Holding AG (LON: 0QQM)
London
· Delayed Price · Currency is GBP · Price in CHF
150.00
-2.00 (-1.32%)
Jan 16, 2025, 1:14 PM BST
IVF Hartmann Holding AG Revenue
IVF Hartmann Holding AG had revenue of 76.51M CHF in the half year ending June 30, 2024, with 4.95% growth. This brings the company's revenue in the last twelve months to 153.26M, up 2.30% year-over-year. In the year 2023, IVF Hartmann Holding AG had annual revenue of 148.31M, down -1.88%.
Revenue (ttm)
153.26M CHF
Revenue Growth
+2.30%
P/S Ratio
n/a
Revenue / Employee
561.38K CHF
Employees
273
Market Cap
317.50M GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 148.31M | -2.84M | -1.88% |
Dec 31, 2022 | 151.15M | 6.35M | 4.38% |
Dec 31, 2021 | 144.80M | -29.16M | -16.76% |
Dec 31, 2020 | 173.96M | 34.94M | 25.13% |
Dec 31, 2019 | 139.02M | 4.97M | 3.71% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |